Synlogic to Webcast Presentation at the Cowen and Company 38th Annual Health Care Conference
March 05 2018 - 4:05PM
Business Wire
Synlogic (Nasdaq:SYBX) announced today that JC Gutiérrez-Ramos,
Ph.D., Synlogic’s president and chief executive officer, will
present a corporate update at the Cowen and Company 38th Annual
Health Care Conference at 3:30 p.m. ET on Monday, March 12, 2018,
in Boston, MA.
A live webcast of the presentation can be accessed under “Event
Calendar” in the Investors & Media section of the Company’s
website. An archived webcast recording will be available on the
Synlogic website for approximately 30 days after the event.
About Synlogic:Synlogic is pioneering the development of
a novel class of living treatments, Synthetic Biotic™ medicines,
based on its proprietary drug development platform. Synlogic’s
initial pipeline includes Synthetic Biotic medicines for the
treatment of rare genetic diseases, such as Urea Cycle Disorder
(UCD) and Phenylketonuria (PKU). In addition, the company is
leveraging the broad potential of its platform to create Synthetic
Biotic medicines for the treatment of more common diseases,
including liver disease, inflammatory and immune disorders, and
cancer. Synlogic is collaborating with AbbVie to develop Synthetic
Biotic-based treatments for inflammatory bowel disease (IBD). For
more information, please visit www.synlogictx.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180305006185/en/
MEDIA CONTACT:Courtney Heath,
617-872-2462courtney@scientpr.comorINVESTOR
CONTACT:Elizabeth Wolffe, Ph.D.,
617-207-5509liz@synlogictx.com
Synlogic (NASDAQ:SYBX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Synlogic (NASDAQ:SYBX)
Historical Stock Chart
From Apr 2023 to Apr 2024